NCT00005028 2019-11-04
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
University of Maryland, Baltimore
Phase 2 Completed
Clinical Trials
20 trialsNCT00087425 2015-04-30
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006389 2014-10-01
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003936 2014-04-11
Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00006942 2013-08-26
Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005965 2013-07-10
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004008 2013-06-26
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005056 2013-06-26
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003443 2013-06-24
Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00003205 2013-05-30
Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
University of Colorado, Denver
Phase 2 Completed
NCT00002907 2013-04-05
Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00002908 2013-04-05
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003171 2013-04-05
Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003220 2013-04-05
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00005849 2013-02-11
Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
University of Chicago
Phase 2 Completed
NCT00003968 2013-02-08
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002725 2013-02-05
Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00058305 2013-01-10
Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
National Cancer Institute (NCI)
Phase 2 Completed
NCT00136461 2011-03-10
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00017342 2010-03-01
Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
Virginia Commonwealth University
Phase 2 Completed